The Capital Market Authority announces the issuance of its decision approving the request of Dallah Healthcare Company to increase its capital from (1,015,747,690) riyals to (1,218,897,230) riyals by granting (1) free share for every (5) existing shares held by shareholders registered in the issuer’s shareholder register at the Securities Depository Center at the end of the second trading day following the entitlement date, which will be determined by the company’s board of directors at a later time. The capital increase will be paid by transferring an amount of (109,534,568) riyals from the “Issuance Premium” item and an amount of (93,614,972) riyals from the “Statutory Reserve” item. Consequently, the number of shares will increase from (101,574,769) shares to (121,889,723) shares, an increase of (20,314,954) shares. The date of the extraordinary general assembly meeting shall not exceed six months from the date of this approval, and the company shall complete the relevant regulatory procedures and requirements.